Multiple regression analysis for determining factors affecting the J-OSDI scores. by Minako Kaido (309626)

Subjects:

The effect of instilling the ophthalmic solution on the LF/HF ratio and typical cases of fluctuations in the LF/HF ratio over time in the DE and non-DE groups. by Minako Kaido (309626)

Subjects:

Anti-CD25 treatment depletes Foxp3^GFP Treg cells and induces decreased fungal loads in Foxp3^GFP C57BL/6 mice. by Maíra Felonato (296591)

Fig 5 - by Fatemeh Mohammadkhani (15927311)

Total, free, and bound thrombin of 10,000 simulations of blood clotting over collagen/ TF under venous flow rate. by Jason Chen (15937)

Fibrin concentration of 10,000 simulations compared to experimental data of blood clotting over collagen/ TF under venous flow rate. by Jason Chen (15937)

Kaplan-Meier survival curves for overall survival of MBC by highest tertile of IFN-γ signature vs. the lowest two tertiles. by Christina Gillezeau (5348660)

Subjects:

Study flow diagram. by Christina Gillezeau (5348660)

Subjects:

Kaplan–Meier survival curves for overall survival of NMIBC by highest tertile of IFN-γ signature vs the lowest two tertiles. by Christina Gillezeau (5348660)

Subjects:

Sample flow diagram. by Christina Gillezeau (5348660)

Subjects:

Kaplan-Meier survival curves for overall survival of MIBC by highest tertile of IFN-γ signature vs the lowest two tertiles. by Christina Gillezeau (5348660)

Subjects:

Kaplan-Meier survival curves for progression-free survival of MIBC by highest tertile of IFN-γ signature vs the lowest two tertiles. by Christina Gillezeau (5348660)

Subjects:

Characteristics of bladder cancer patients by stage. by Christina Gillezeau (5348660)

Subjects:

Hazard ratios (HR) and 95% confidence intervals (CI) for the association between INF- γ signature levels and death among bladder cancer patients by stage. by Christina Gillezeau (5348660)

Subjects:

Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates. by Xiaoyan Xia (560153)

“…One circle represents one hospital, with blue (<i>n</i> = 20), green (<i>n</i> = 36), orange (<i>n</i> = 34), and purple (<i>n</i> = 22) representing baseline CS rates of <30%, 30%–39%, 40%–49%, and ≥50%, respectively. The absolute decrease = the CS rate at baseline − the CS rate in Stage 2; the relative decrease = (the CS rate at baseline − the CS rate in Stage 2) ÷ the CS rate at baseline. …”

Changes in mean end-expiratory diaphragm thickness over time during mechanical ventilation in each group. by Taiga Itagaki (8069489)

National C-BARQ breed and all-breed means from USA. by Kyle R. Bohland (16839147)

DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Sensitivity analysis heatmap for perturbations of 1%, 10%, and 50% in optimized parameters with Covid-19 data in Brazil. by Hélder Seixas Lima (18840636)

5-ALA staining of gastrointestinal cancer cells. by Noriko Kawai (6694010)